Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biodesix (BDSX) Intangibles (2019 - 2025)

Biodesix (BDSX) has disclosed Intangibles for 7 consecutive years, with $19.0 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Intangibles rose 222.95% year-over-year to $19.0 million, compared with a TTM value of $19.0 million through Dec 2025, up 222.95%, and an annual FY2025 reading of $19.0 million, up 222.95% over the prior year.
  • Intangibles was $19.0 million for Q4 2025 at Biodesix, up from $5.9 million in the prior quarter.
  • Across five years, Intangibles topped out at $19.0 million in Q3 2024 and bottomed at $5.9 million in Q4 2024.
  • Average Intangibles over 5 years is $12.4 million, with a median of $10.7 million recorded in 2022.
  • The sharpest move saw Intangibles plummeted 47.76% in 2022, then soared 222.95% in 2025.
  • Year by year, Intangibles stood at $18.8 million in 2021, then tumbled by 47.76% to $9.8 million in 2022, then fell by 19.25% to $7.9 million in 2023, then decreased by 25.75% to $5.9 million in 2024, then skyrocketed by 222.95% to $19.0 million in 2025.
  • Business Quant data shows Intangibles for BDSX at $19.0 million in Q4 2025, $5.9 million in Q4 2024, and $19.0 million in Q3 2024.